Skip to main content

Q1/25: Strong start to 2025 – #FutureFresenius REJUVENATE phase kicked-off with excellent momentum

Annual General Meeting 2025

May 23, 2025
Frankfurt, Germany

Annual General Meeting 2025

Information, Documents and Shareholder Online Service

Next event

Financial Highlights Q1/2025

Group Revenue 1

5631 m

+7% 2

Q1/24: €5,283 m

Group EBIT 1

654 m

+4% 3

Q1/24: €631 m

Net income 1, 4

416 m

+12% 3

Q1/24: €371 m

EPS 1, 4

0.74

+12% 3

Q1/24: €0.66

KABI Revenue 1

2146 m

+6% 2

Q1/24: €2,051 m

HELIOS Revenue

3394 m

+8% 1

Q1/24: €3,154 m

1 Before special items

2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation

3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation

4 Excluding Fresenius Medical Care

2024 – What a successful year!

Listen to CEO Michael Sen on how our #FutureFresenius transformation is clearly paying off: today, we are a simpler, more focused, and stronger healthcare company.

Tune in!

 

News